
    
      Subjects were vaccinated with ASP4070 or placebo at 2 week intervals. Clinical symptoms were
      evaluated after cedar pollen exposure in a chamber at 4, 8 and 12 weeks after the last
      vaccination to identify the timing of the onset of therapeutic effect.
    
  